Search results
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Morningstar· 2 weeks agoGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential ...
Nanobiotix reports progress and financial results for 2023 By Investing.com
Investing.com· 2 weeks agoThe company highlighted the expansion of its radioenhancer NBTXR3's global potential through a...
Microbiome researchers challenge the state of the art in colon cancer biomarker discovery
Medical Xpress· 6 days agoFor the first time, researchers from VIB-KU Leuven, UZ Leuven, Janssen Pharmaceutica and multiple...